Storage and handling
Storage: Store at room temperature. Do not freeze.
Storage: Store at room temperature. Do not freeze.
ClxDerm™ 4% chlohexidine
digluconate antiseptic shampoo
for dogs and cats
Warning: Keep out of reach of children.
ClxDerm™ 4% chlohexidine digluconate antiseptic shampoo designed for cleansing the skin of dogs and cats. Chlorhexidine, the active ingredient in ClxDerm™ shampoo 4%, has been proven effective against a broad-spectrum of micro-organisms sensitive to chlorhexidine. The use of ClxDerm™ 4% chlohexidine digluconate antiseptic shampoo will aid in the management of skin infections, supporting a healthy skin barrier.
Directions for use: Wet your pet with warm water and apply shampoo. Massage into wet haircoat. Allow to remain on haircoat for 5-10 minutes before rinsing thoroughly with clean water. Repeat as needed. To improve skin condition, shampoo 1 to 2 times per week in a 1 to 2 week period, or as directed by your veterinarian. To maintain healthy skin, shampoo at least once per month or as directed by your veterinarian.
For external use on dogs and cats only. May cause skin or eye irritation. Avoid getting shampoo in your pet's eyes. In case of contact with eyes, rinse thoroughly with water and consult a veterinarian. If skin irritation occurs and persists, discontinue use and contact your veterinarian. Consult a veterinarian before using on pregnant, lactating or breeding animals; puppies; kittens; or animals with a pre-existing medical condition. Use with caution in older animals. If an animal has an adverse reaction to treatment, discontinue use and contact your veterinarian.
Storage: Store at room temperature. Do not freeze.
Chlorhexidine digluconate 4%.
Inactive ingredient(s): deionized water, fragrance, glycerin, hydroxypropyl guar, isodecyl alcohol ethoxylate, lanolin ethoxylated, lauramine oxide, myristamine oxide propylene glycol, Tris-EDTA.
For use on dogs and cats only to maintain healthy skin and hair and to enhance hygiene. Aids in the management of skin infections associated with micro-organisms that are sensitive to chlorhexidine.
Manufacturer:
iCF™
Evolution of
Knowledge
a division of nextmune
NEXTMUNE ITALY S.R.L.
Via G.B. Benzoni, 50 - 26020
PALAZZO PIGNANO (CR) Italy
Tel. +39 0373 982024;
+39 0373 938345
e-mail:info@icfsrl.it
customercare@drnsrl.it
Distributor:
Nextmune US, LLC
2801 S. 35th St.,
Phoenix, AZ 85034
480-464-8971
made
in Spain
| Class | Version | Type | Effective |
|---|---|---|---|
| CHLORHEXIDINE Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 77dc03a4-fbfc-e6a3-fe95-285bbae40d75 | Product name | 2 | 20250814 |
| 6c13b22c-b3ba-4127-b768-0132dd5ab0d1 | Product name | 1 | 20230829 |
| bb6d6c68-649d-4e6d-a1f6-603d969c8f68 | Product name | 1 | 20160303 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 86127-001-01 | Clx Derm | 250 mL in 1 BOTTLE, PLASTIC | SHAMPOO | 250 | 3 | |
| 86127-001-01 | Clx Derm | 1 in 1 CARTON | SHAMPOO | 1 | 3 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 86127-001 | 86127-001-01 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| CHLORHEXIDINE GLUCONATE | MOR84MUD8E | ACTIB |
| water | 059QF0KO0R | IACT |
| glycerin | PDC6A3C0OX | IACT |
| propylene glycol | 6DC9Q167V3 | IACT |
| GUARAPROLOSE (3500 MPA.S AT 1%) | 3A1I7376TC | IACT |
| isodecyl alcohol | 3160X491M7 | IACT |
| PEG-75 Lanolin | 09179OX7TB | IACT |
| TROMETHAMINE | 023C2WHX2V | IACT |
| EDETATE SODIUM | MP1J8420LU | IACT |
| MYRISTAMINE OXIDE | J086PM3RRT | IACT |
| LAURAMINE OXIDE | 4F6FC4MI8W | IACT |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Adverse event summaries are temporarily unavailable. Other product information remains available.